Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Shutdown Week Three: Sponsors With Upcoming User Fee Dates Should Start Sweating

Executive Summary

US FDA has enough carryover funding for another month of operations, Commissioner Gottlieb says, potentially endangering late February and March review goals.
Advertisement

Related Content

US FDA Brings Back Furloughed Workers To Inspect High-Risk Facilities
Shutdown Week Four: FDA Maintains Pre-Shutdown Output Pace In Some Cases
J.P. Morgan 2019: Biopharma Sentiment Soars As Deal And Financing Optimism Abounds
Is There A REMS In Uloric’s Future? US FDA Panelists Say Yes, Agency Says Not Likely
J.P. Morgan Notebook Day 3: Biotech Feeling Government Shutdown, AstraZeneca, Denali, Allergan, Aptinyx, Sangamo
Recent And Upcoming FDA Advisory Committee Meetings
Shutdown Shout-out: US FDA Commissioner Steps Up Communication In Tough Time
As US FDA Shutdown Continues, What Will Be The Cost Of Not Spending?
The Big Spend-Down: US FDA Eyes $159M Reduction In Carryover User Fees
PDUFA Fees Forced Down For FY 2017 Due To Refund Provision

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS124509

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel